Cleocin Phosphate Injection, Solution
Product Images NDC 0404-9837

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 0404-9837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure diagram of clindamycin phosphate, showing its molecular components including a chlorinated carbon, methyl groups, phosphate group, and a sulfur-containing ring system.*

FDA Label Image

Image1.jpg (Image1)

A data table titled "Average Peak and Trough Serum Concentrations of Active Clindamycin After Dosing with Clindamycin Phosphate". It lists dosage regimens for healthy adult males and pediatric patients with corresponding peak and trough serum clindamycin concentrations in mcg/mL, showing variations by dose and administration method.*

FDA Label Image

Image2.jpg (Image2)

A data table showing infusion rates to maintain serum clindamycin levels. Columns list serum clindamycin levels in mcg/mL, corresponding rapid infusion rates in mg/min with durations of 30 minutes, and maintenance infusion rates in mg/min.*

FDA Label Image

Image3.jpg (Image3)

A data table presenting dosing information for CLEOCIN PHOSPHATE injection solution. It lists dose amounts (300 mg to 1200 mg), corresponding diluent volumes (50 mL to 100 mL), and recommended infusion times (10 to 40 minutes). The table summarizes preparation and administration guidance for different doses.*

FDA Label Image

Image4.jpg (Image4)

A data table listing package sizes and corresponding NDC numbers for various vial volumes including 25-2 mL, 25-4 mL, 25-6 mL vials, and a 5-60 mL pharmacy bulk package. The table pairs these package sizes with their specific NDC codes.*

FDA Label Image

Image5.jpg (Image5)

A table listing NDC codes, vial sizes, and total clindamycin phosphate per vial. The vial sizes are 2 mL, 4 mL, and 6 mL, corresponding to 300 mg, 600 mg, and 900 mg of clindamycin phosphate respectively.*

FDA Label Image

Image6.jpg (Image6)

A data table listing packaging sizes and corresponding NDC numbers for a pharmaceutical product. It shows container quantities of 24 with doses of 300 mg/50 mL, 600 mg/50 mL, and 900 mg/50 mL, each paired with specific NDC codes.*

FDA Label Image

Image7.jpg (Image7)

A data table listing three container sizes of injectable medication doses with their corresponding NDC numbers: 24-300 mg/50 mL, 24-600 mg/50 mL, and 24-900 mg/50 mL containers, along with their NDC numbers 0009-3381-02, 0009-3375-02, and 0009-3382-02 respectively.*

FDA Label Image

Image8.jpg (Image8)

Illustration showing how to remove the flip-off cap from a vial. Figure 1 depicts pressing down and pulling the cap ring, and Figure 2 shows lifting the cap upward to open the vial.*

FDA Label Image

Image9.jpg (Image9)

An instructional illustration showing two steps of opening or preparing a solution bottle with a screw cap. The left image (Fig. 3) depicts a hand gripping the cap to remove it, and the right image (Fig. 4) shows a hand holding the bottle while the cap is partially removed. No product-specific text or other details are visible.*

FDA Label Image

Image10.jpg (Image10)

Illustration showing hands manipulating a medical fluid container with a spout. The first figure shows a hand pressing on the top portion of the container, and the second figure shows the top pressed fully to presumably release or control fluid flow. The images appear instructional for use of the injection solution container.*

FDA Label Image

Label1.jpg (Label1)

Label for CLEOCIN PHOSPHATE (clindamycin phosphate) injection, USP, 300 mg/2 mL (150 mg/mL), single dose vial. It is indicated for intramuscular or intravenous use. Label includes storage instructions, manufacturer Henry Schein, Inc. address, NDC 0404-9837-02, and a barcode. Warning notes mention intravenous dilution before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.